Pfizer Charged With Bribing Doctors in Europe and AsiaVW Staff
Pharmaceutical major Pfizer Inc. (NYSE:PFE) has been reported to have agreed to pay $60 million to the federal government, in settlement of alleged charges that its employees were involved in the bribery of overseas officials and prescribing doctors in Europe and in Asia, in order to generate business.
Pfizer Inc. (NYSE:PFE) had been charged under the Foreign Corrupt Practices Act, which bars listed American companies from . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.